Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Tachyon Therapeutics Inc.

Headquarters: Houston, TX, United States of America
Year Founded: 2019
Status: Private

BioCentury | Mar 1, 2023
Emerging Company Profile

Tachyon’s VC round, CIRM grant drive first-in-class oncology program to clinic

Team including Quanticel co-founders has begun Phase I testing of KDM4 program that had traveled through Celgene, BMS
BioCentury | Sep 25, 2021
Translation in Brief

Verve’s durable PCSK9 base editor; plus Novartis, PureTech and more

BioCentury’s roundup of translational news
BioCentury | Aug 4, 2021
Deals

New deal strategy gives AbCellera more upside without straying from its roots

Tachyon, EQRx deals give AbCellera options to invest in development, gaining more royalties, ownership of assets
BioCentury | Aug 4, 2021
Deals

Aug. 3 Quick Takes: BeiGene picks N.J. for new campus

Plus Zentera, Iterative Scopes, BMS, Novartis, Mestag, Engrail, AbCellera-Tachyon, Outlook
Items per page:
1 - 4 of 4